New 12-Month Tofersen Data Presented at ENCALS Meeting Show Clinically Meaningful Benefit in People…
12-month data show that earlier initiation of tofersen slowed decline across measures of clinical and respiratory function, strength, and quality of lifeTofersen also led to robust and sustained reductions in neurofilament, a marker of…